Fate Therapeutics (FATE) Shares Repurchased (2012 - 2013)
Fate Therapeutics (FATE) reported Shares Repurchased of $56.5 million for Q4 2013, up 383.59% on a YoY basis from $11.7 million in Q4 2012, and up 383.59% quarter-over-quarter from $11.7 million in Q4 2012.
Fate Therapeutics (FATE) Shares Repurchased (2012 - 2013) Analysis & Trends
Fate Therapeutics has reported Shares Repurchased for 2 years, with the latest figure at $56.5 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 839,896.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 336.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 56.50 Mn |
| Dec 31, 2013 | 56.50 Mn |
| Dec 31, 2012 | 11.68 Mn |
| Dec 31, 2012 | 11.68 Mn |